16
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Arteriogenesis The Development and Growth of Collateral Arteries

&
Pages 83-97 | Published online: 10 Jul 2009

REFERENCES

  • Abbruzzese TA, Guzman RJ, Martin RL, Yee C, Za-rins CK, Dalman RL. (1998). Matrix metallopro-teinase inhibition limits arterial enlargements in a rodent arteriovenous fistula model. Surgery 124: 328-334.
  • Abrams HL. (1983). Caldwell Lecture. The collat-eral circulation: response to ischemia. Am J Roent-genol 140: 1051-1063.
  • American Heart Association. (2001). 2002 Heart and Stroke Statistical Update. Dallas, TX: Ameri-can Heart Association.
  • Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. (1998). Monocyte activation in angio-genesis and collateral growth in the rabbit hindlirnb. J Clin Invest 101: 40-50.
  • Asahara T, Masuda H, Takahashi T, Kalka C, Pas-tore C, Silver M, Kearne M, Magner M, Isner ym. (1999). Bone marrow origin of endothelial progeni-tor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228.
  • Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
  • Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF. (1994). Angiogenic-induced enhancement of collat-eral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89: 2183-2189.
  • Baroldi G, Mantero O, Scomazzoni G. (1956). The collaterals of the coronary arteries in normal and pathological hearts. Circ Res 4: 223-229.
  • Baroldi G, Scomazzoni G. (1967). Coronary Cir-culation in the Normal and the Pathological Heart. Washington, DC: US Government Printing Office.
  • Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. (1992). Vascular permeability factor (vascular endothelial growth factor) gene is ex-pressed differentially in normal tissues, macro-phages, and tumors. Mol Biol Cell 3: 211-220.
  • Bloor CM, Liebow AA. (1965). Coronary collateral circulation. Am J Cardiol 16: 238-252.
  • Bloor CM, White FC. (1972). Functional develop-ment of the coronary collateral circulation during coronary artery occlusion in the conscious dog. Am J Pathol 67: 483-500.
  • Borgers M, Schaper J, Xhonneux R, Schaper W. (1973). Hydrocortisone influences developing col-laterals. 2. A cytochemical study. Virchows Arch A Pathol Pathol Anat 361: 283-297.
  • Browder T, Folkman J, Pine-Shepherd S. (2000). The hemostatic system as a regulator of angiogene-sis. J Biol Chem 275: 1521-1524.
  • Brown DM, Hong SP, Farrell CL, Pierce GF, Khouri RK. (1995). Platelet-derived growth factor BB in-duces functional vascular anastomoses in vivo. Proc Natl Acad Sci USA 92: 5920-5924.
  • Buschrnann IR, Hoefer IF, van Royen N, Katzer E, Braun-Dulleaus R, Heil M, Kostin S, Bode C, Schaper W. (2001). GM-CSF: A strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis 159: 343-356.
  • Busiek DF, Baragi V, Nehring LC, Parks WC, Wel-gus HG. (1995). Matrilysin expression by human mononuclear phagocytes and its regulation by cyto-kines and hormones. J Immunol 154: 6484-6491.
  • Cai W, Vosschulte R, Afsah-Hedjri A, Koltai S, Koc-sis E, Scholz D, Kostin S, Schaper W, Schaper J. (2000). Altered balance between extracellular pro-teolysis and antiproteolysis is associated with adap-tive coronary arteriogenesis. J Mol Cell Cardiol 32: 997-1011.
  • Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalrna T, Dewerchin M, Noel A, Stalrnans I, Barra A, Blacher S, Vanden-driessche T, Ponten A, Eriksson U, Plate KH, Foi-dart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG. (2001). Syn-ergism between vascular endothelial growth factor and placental growth factor contributes to angiogen-esis and plasma extravasation in pathological con-ditions. Nat Med 7: 575-583.
  • Carroll SM, White FC, Roth DM, Bloor CM. (1993). Heparin accelerates coronary collateral development in a porcine model of coronary artery occlusion. Cir-culation 88: 198-207.
  • Ceiler DL, De Mey JG. (2000). Chronic N(G)-nitro-L-arginine methyl ester treatment does not prevent flow-induced remodeling in mesenteric feed arteries and arcading arterioles. Arterioscler Thromb Vasc Biol 20: 2057-2063.
  • Celletti FL, Waugh EVI, Arnabile PG, Brendolan A, Hilfiker PR, Dake MD. (2001). Vascular endothelial growth factor enhances atherosclerotic plaque pro-gression. Nat Med 7: 425-429.
  • Chae JK, Kim I, Lim ST, Chung MJ, Kim WH, Kim HG, Ko JK, Koh GY. (2000). Coadministration of angiopoietin-1 and vascular endothelial growth fac-tor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 20: 2573-2578.
  • Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, Risau W. (1996). The vascular en-dothelial growth factor receptor Flt-1 mediates bio-logical activities: Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271: 17629-17634.
  • Cox RH. (1979) Physiology and hemodynamics of the macrocirculation. In: Stehbens WE, editor. He-modynamics and the Blood Vessel Wall. Springfield, IL: Charles C. Thomas, 75-156.
  • Coyle P. (1984). Diameter and length changes in cerebral collaterals after middle cerebral artery oc-clusion in the young rat. Anat Rec 210: 357-364.
  • Davies PF, Barbee KA, Volin MV, Robotewskyj A, Chen J, Joseph L, Griem ML, Wernick MN, Jacobs E, Polacek DC, de Paola N, Barakat Al. (1997). Spa-tial relationships in early signaling events of flow-mediated endothelial mechanotransduction. Annu Rev Physiol 59: 527-549.
  • Davies PF, Remuzzi A, Gordon EJ, Dewey CF Jr, Gimbrone MA Jr. (1986). Turbulent fluid shear stress induces vascular endothelial cell turnover in vitro. Proc Natl Acad Sci USA 83: 2114-2117.
  • Deindl E, Fernandez B, Ziegelhoeffer T, Schaper W. (2001). Collateral artery growth is associated with an increased expression of Egr-1. FASER J 15(suppl): A1079. Abstract 798.7.
  • Dobbs SL, Roth DM, Bloor CM, White FC. (1991). Effects of age on coronary collateral development. Coron Artery Dis 2: 473-480.
  • Egginton S, Zhou AL, Brown MD, Hudlicka O. (2001). Unorthodox angiogenesis in skeletal muscle. Cardiovasc Res 49: 634-646.
  • Epstein SE, Fuchs S, Zhou YF, Baffour R, Kor-nowski R. (2001). Therapeutic interventions for en-hancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res 49: 532-542.
  • Folkman J. (1995). Angiogenesis in cancer, vascu-lar, rheumatoid and other disease. Nat Med 1: 27-31.
  • Fuchs S, Baffour R, Zhou YF, Shou M, Pierre A, Tio FO, Weissman NJ, Leon MB, Epstein SE, Kornowski R. (2001). Transendocardial delivery of autologous bone marrow enhances collateral perfusion and re-gional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37: 1726-1732.
  • Fujita M, Ikemoto M, Kishishita M, Otani H, Nohara R, Tanaka T, Tarnaki S, Yarnazato A, Sasayarna S. (1996). Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 94: 610-613.
  • Fulton WFM. (1965). The Coronary Arteries. Springfield, IL: Charles C. Thomas.
  • Galls ZS, Khatri JJ. (2002). Matrix metalloprotein-ases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 90: 251-262.
  • Galls ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P. (1995). Macrophage foam cells from ex-perimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 92: 402-406.
  • Garcia-Cardena G, Comander JI, Blackman BR, Anderson KR, Girnbrone MA. (2001). Mechanosen-sitive endothelial gene expression profiles: Scripts for the role of hemodynarnics in atherogenesis? Ann N Y Acad Sci 947: 1-6.
  • Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Girnbrone MA Jr, Luster AD, Luscin-skas FW, Rosenzweig A. (1999). MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular en-dothelium under flow conditions. Nature 398: 718-723.
  • Girerd X, London G, Boutouyrie P, Mourad JJ, Safar M, Laurent S. (1996). Remodeling of the radial ar-tery in response to a chronic increase in shear stress. Hypertension 27: 799-803.
  • Gorge G, Schmidt T, Ito BR, Pantely GA, Schaper W. (1989). Microvascular and collateral adaptation in swine hearts following progressive coronary ar-tery stenosis. Basic Res Cardiol 84: 524-535.
  • Haas TL, Stitelrnan D, Davis SJ, Apte SS, Madri JA. (1999). Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metallo-proteinase in endothelium. J Biol Chem 274: 22679-22685.
  • Hansen-Smith F, Egginton S, Zhou AL, Hudlicka O. (2001). Growth of arterioles precedes that of capil-laries in stretch-induced angiogenesis in skeletal muscle. Microvasc Res 62: 1-14.
  • Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, Tsao PS, Johnson FL, Cooke JP. (2001). Nico-tine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 7: 833-839.
  • Heil M, Clauss M, Suzuki K, Buschrnann IR, Willu-weit A, Fischer S, Schaper W. (2000). Vascular en-dothelial growth factor (VEGF) stimulates mono-cyte migration through endothelial monolayers via increased integrin expression. Eur J Cell Biol 79: 850-857.
  • Heil M, Pipp F, Clauss M, Fischer SV, Schaper W. (2001). Placenta growth factor cooperates with MCP-1 in stimulating collateral artery growth by a rapid monocyte activation. Eur Heart J 22 (suppl): 152. Abstract P953
  • Helisch A, Schaper W. (2000). Angiogenesis and ar-teriogenesis-not yet for prescription. Z Kardiol 89: 239-244.
  • Henry TD, Annex BH, Azrin MA, McKendall GR, Willerson JT, Hendel RC, Giordano F, Klein R, Gib-son M, Berman DS, Luce CA, McCluskey ER. (1999). Final results of the VIVA trial of rhVEGF for human therapeutic angiogenesis. Circulation 100: 1-476.
  • Hershey JC, Baskin EP, Glass JD, Hartman HA, Gil-berto DB, Rogers IT, Cook JJ. (2001). Revascular-ization in the rabbit hincllirnb: dissociation between capillary sprouting and arteriogenesis. Cardiovasc Res 49: 618-625.
  • Herzog M, Sager H, Khmelevski E, Deylig A, Ito W. (2002). Collateral arteries grow from preexisting anastomoses in the rat hindlirnb. Am J Physiol Heart Circ Physiol 283: H2012-H2020.
  • Hoefer IE, van Royen N, Buschrnann IR, Piek JJ, Schaper W. (2001). Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res 49: 609-617.
  • Hoiberg D, editor. Britannica DVD 99 Multimedia Edition. Chicago, IL: Encyclopedia Britiannica, Inc., 1999.
  • Hollenberg NK. (1992) Collateral arterial growth and reactivity: lessons from the limb and renal blood supply. In: Schaper W, Schaper, J, editors. Collat-eral Circulation: Heart, Brain, Kidney, Limbs. Bos-ton, MA: Kluwer Academic, 1-15.
  • Hossmann K-A. (1992) Collateral circulation of the brain. In: Schaper W, Schaper, J, editors. Collateral Circulation: Heart, Brain, Kidney, Limbs. Boston, MA: Kluwer Academic, 291-315.
  • Isner YM, Baumgartner I, Rauh G, Schainfeld R, Blair R, Manor O, Razvi S, Symes JF. (1998). Treat-ment of thromboangiitis obliterans (Buerger's dis-ease) by intramuscular gene transfer of vascular en-dothelial growth factor: preliminary clinical results. J Vasc Surg 28: 964-973.
  • Ito WD, Arras M, Scholz D, Winkler B, Htun P, Schaper W. (1997). Angiogenesis but not collateral growth is associated with ischemia after femoral ar-tery occlusion. Am J Physiol 273: H1255-H1265.
  • Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. (1997). Monocyte chemotactic pro-tein-1 increases collateral and peripheral conduc-tance after femoral artery occlusion. Circ Res 80: 829-837.
  • Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsurni Y, Ozono R, Masaki H, Mori Y, Iba O, Tateishi E, Kosaki A, Shintani S, Murohara T, Irnai-zurni T, Iwasaka T. (2001). Implantation of bone marrow mononuclear cells into ischemic myocar-dium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104: 1046-1052.
  • Karniya A, Togawa T. (1980). Adaptive regulation of wall shear stress to flow change in the canine carotid artery. Am J Physiol 239: H14-H21.
  • Karnpmann A, Fernandez B, Kubin T, Pipp F, von der Ahe D, Schaper W, Zimmermann R. (2001). Osteoglycin: a potential target for the promotion of arteriogenesis? Circulation 104(suppl): 11-235. 1133 Abstract.
  • Kranz A, Rau C, Kochs M, Waltenberger J. (2000). Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction: Evidence for its origin and functional significance. J Mol Cell Cardiol 32: 65-72.
  • Laharn RJ, Sellke FW, Edelman ER, Pearlman JD, Ware JA, Brown DL, Gold JP, Simons M. (1999). Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary by-pass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100: 1865-1871.
  • Langille BL, O'Donnell F. (1986). Reductions in ar-terial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 231: 405-407.
  • Lee RT, Schoen FJ, Loree HM, Lark MW, Libby P. (1996). Circumferential stress and matrix metallo-proteinase 1 in human coronary atherosclerosis. Im-plications for plaque rupture. Arterioscler Thromb Vasc Biol 16: 1070-1073.
  • Lehman RM, Owens GK, Kassell NF, Hongo K. (1991). Mechanism of enlargement of major cere-bral collateral arteries in rabbits. Stroke 22: 499-504.
  • Lloyd PG, Yang HT, Terjung RL. (2001). Arterio-genesis and angiogenesis in rat ischemic hindlirnb: Role of nitric oxide. Am J Physiol Heart Circ Physiol 281: H2528-H2538.
  • Longland CJ. (1953). The collateral circulation of the limb. Ann R Coll Surg Engl 13: 161-176.
  • Lower R. (1968) De corde, London 1669. In: Gun-ther RT, editor. Early Science in Oxford. London, UK: Dawsons of Pall Mall.
  • Martins RN, Chleboun JO, Sellers P, Sleigh M, Muir J. (1994). The role of PDGF-BB on the development of the collateral circulation after acute arterial oc-clusion. Growth Factors 10: 299-306.
  • Maseri A, Araujo L, Finocchiaro ML. (1993) Collateral development and function in man. In: Schaper W, Schaper, J, editors. Collateral Circulation: Heart, Brain, Kidney, Limbs. Boston, MA: Kluwer Academic Publisher, 381-402.
  • Masuda H, Zhuang YJ, Singh TM, Kawamura K, Murakarni M, Zarins CK, Glagov S. (1999). Adap-tive remodeling of internal elastic lamina and endo-thelial lining during flow-induced arterial enlarge-ment. Arterioscler Thromb Vasc Biol 19: 2298-2307.
  • Matsunaga T, Warltier DC, Weihrauch DW, Moniz M, Tessmer J, Chilian WM. (2000). Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 102: 3098-3103.
  • Max-well MP, Hearse DJ, Yellon DM. (1987). Species variation in the coronary collateral circulation dur-ing regional myocardial ischaemia: A critical deter-minant of the rate of evolution and extent of myo-cardial infarction. Cardiovasc Res 21: 737-746.
  • McCarthy MJ, Loftus IM, Thompson 1VELVI, Jones L, London NJ, Bell PR, Naylor AR, Brindle NP. (1999). Angiogenesis and the atherosclerotic carotid plaque: An association between symptomatology and plaque morphology. J Vasc Surg 30: 261-268.
  • Mooradian DL, Hutsell TC, Keefer LK. (1995). Ni-tric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol 25: 674-678.
  • Moulton KS, Heller E, Konerding MA, Flynn E, Pa-linski W, Folkman J. (1999). Angiogenesis inhibi-tors endostatin or TNP-470 reduce intirnal neovas-cularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99: 1726-1732.
  • Murohara T, Asahara T, Silver M, Bauters C, Ma-suda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, Isner ym. (1998). Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578.
  • Nagel T, Resnick N, Dewey CF Jr, Girnbrone MA Jr. (1999). Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activa-tion of transcription factors. Arterioscler Thromb Vasc Biol 19: 1825-1834.
  • Newman MF, Kirchner JL, Phillips-Bute B, Gayer V, Grocott H, Jones RH, Mark DB, Reves JG, Blumen-thal JA. (2001). Longitudinal assessment of cognitive function function after coronary: Artery bypass sur-gery. N Engl J Med 344: 395-402.
  • Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ. (1992). Molecular cloning and characterization of the constitutive bovine aortic en-dothelial cell nitric oxide synthase. J Clin Invest 90: 2092-2096.
  • O'Callaghan CJ, Williams B. (2000). Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells: Role of TGF-beta(1). Hypertension 36: 319-324.
  • Pipp F, Heil M, Clauss M, Herold J, Tribulova S, Schaper W. (2002). Vergleich von VEGF und MCP-1 im ischamischen Kaninchenhinterlauf [Comparison of VEGF and MCP-1 in the ischemic rabbit hindlirnb]. Z Kardiol 91(suppl): 1/5. Abstract V11.
  • Polverini PJ, Cotran PS, Girnbrone MA, Jr, Unanue ER. (1977). Activated macrophages induce vascular proliferation. Nature 269: 804-806.
  • Ray Chaudhury A, Frischer H, Malik AB. (1996). Inhibition of endothelial cell proliferation and bFGF-induced phenotypic modulation by nitric ox-ide. J Cell Biochem 63: 125-134.
  • Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF Jr, Girnbrone MA Jr. (1993). Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci USA 90: 4591-4595.
  • Risau W. (1997). Mechanisms of angiogenesis. Na-ture 386: 671-674.
  • Risau W, Flainme I. (1995). Vasculogenesis. Annu Rev Cell Dev Biol 11: 73-91.
  • Rohovsky S, Kearney M, Pieczek A, Rosenfield K, Schainfeld R, D'Arnore PA, Isner JM. (1996). El-evated levels of basic fibroblast growth factor in pa-tients with limb ischemia. Am Heart J 132: 1015-1019.
  • Roth DM, White FC, Bloor CM. (1988). Altered minimal coronary resistance to antegrade reflow af-ter chronic coronary artery occlusion in swine. Circ Res 63: 330-339.
  • Sato J, Nair K, Hiddinga J, Eberhardt NIL, Fitzpa-trick LA, Katu sic ZS, O'Brien T. (2000). eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis. Cardiovasc Res 47: 697-706.
  • Schaper J, Borgers M, Xhonneux R, Schaper W. (1973). Cortisone influences developing collaterals: 1. A morphologic study. Virchows Arch A Pathol Pathol Anat 361: 263-282.
  • Schaper J, König R, Franz D, Schaper W. (1976). The endothelial surface of growing coronary collat-eral arteries: Intirnal margination and diapedesis of monocytes; A combined SEM and TEM study. Vir-chows Arch A Pathol Anat Histol 370: 193-205.
  • Schaper W. (1971). The Collateral Circulation of the Heart. Vol. 1. Amsterdam, the Netherlands: North-Holland.
  • Schaper W. (1984) Experimental infarcts and the microcirculation. In: Hearse DJ, Yellon, DM, editors. Therapeutic Approaches to Myocardial Infarct Size Limitation. New York, NY: Raven Press, 79-90.
  • Schaper W. (1967). Tangential wall stress as a molding force in the development of collateral ves-sels in the canine heart. Experientia 23: 595-596.
  • Schaper W, Bernotat-Danielowski S, Nienaber C, Schaper J. (1992) Collateral circulation. In: Fozzard HA, Haber, E, Jennings, RB, editors. The Heart and Cardiovascular System. Second edition. New York, NY: Raven Press, 1427-1464.
  • Schaper W, De Brabander M, Lewi P. (1971). DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res 28: 671-679.
  • Schaper W, Flarneng W, Winkler B, Wusten B, Turschrnann W, Neugebauer G, Carl M, Pasyk S. (1976). Quantification of collateral resistance in acute and chronic experimental coronary occlusion in the dog. Circ Res 39: 371-377.
  • Schaper W, Ito WD. (1996). Molecular mechanisms of coronary collateral vessel growth. Circ Res 79: 911-919.
  • Schaper W, Jageneau A, Xhonneux R. (1967). The development of collateral circulation in the pig and dog heart. Cardiology 51: 321-335.
  • Schaper W, Piek JJ, Munoz-Chapuli R, Wolf C, Ito W. (1999) Collateral circulation of the heart. In: Ware JA, Simons, M, editors. Angiogenesis and Car-diovascular Disease. New York, NY: Oxford Univer-sity Press, 159-198.
  • Scheel KW, Fitzgerald EM, Martin RO, Larsen RA. (1979) The possible role of mechanical stresses on coronary collateral development during gradual coronary occlusion. In: Schaper W, editor. The Pathophysiology of Myocardial Perfusion. Amster-dam, the Netherlands: Elsevier/North-Holland, 489-518.
  • Scholz D, Ito W, Fleming I, Deindl E, Sauer A, Wies-net M, Busse R, Schaper J, Schaper W. (2000). Ul-trastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Vir-chows Arch 436: 257-270.
  • Scholz D, Ziegelhoeffer T, Helisch A, Wagner S, Friedrich C, Podzuweit T, Schaper W. (2002). Con-tribution of arteriogenesis and angiogenesis to post-occlusive hindlirnb perfusion in mice. J Mol Cell Cardiol.
  • Schoop W. (1993) Limb collaterals. In: Schaper W, Schaper, J, editors. Collateral Circulation: Heart, Brain, Kidney, Limbs. Boston, MA: Kluwer Aca-demic Publisher, 317-327.
  • Seiler C, Pohl T, Wustrnann K, Hutter D, Nicolet PA, Windecker S, Eberli FR, Meier B. (2001). Pro-motion of collateral growth by granulocyte-macro-phage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 104: 2012-2017.
  • Sellke FW, Wang SY, Friedman M, Harada K, Edel-man ER, Grossman W, Simons M. (1994). Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Am J Physiol 267: H1303-H1311.
  • Shyy JY, Lin MC, Han J, Lu Y, Petrirne M, Chien S. (1995). The cis-acting phorbol ester "12-0-tetra-decanoylphorbol 13-acetate"-responsive element is involved in shear stress-induced monocyte chemo-tactic protein 1 gene expression. Proc Natl Acad Sci USA 92: 8069-8073.
  • Silvestre JS, Mallat Z, Tarnarat R, Duriez M, Tedgui A, Levy BI. (2001). Regulation of matrix metallo-proteinase activity in ischemic tissue by interleukin-10: Role in ischemia-induced angiogenesis. Circ Res 89: 259-264.
  • Simons M. (2001). Therapeutic coronary angiogen-esis: A fronte praecipitiurn a tergo lupi? Am J Physiol Heart Circ Physiol 280: H1923-H1927.
  • Simons M, Annex BH, Laharn RJ, Kleiman N, Henry T, Dauerman H, Udelson JE, Gervino EV, Pike M, Whitehouse MJ, Moon T, Chronos NA. (2002). Pharmacological treatment of coronary artery dis-ease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial. Circulation 105: 788-793.
  • Thakur NK, Hayashi T, Surni D, Kano H, Matsui-Hirai H, Tsunekawa T, Iguchi A. (2002). Anti-atherosclerotic effect of beta-blocker with nitric ox-ide-releasing action on the severe atherosclerosis. J Cardiovasc Pharmacol 39: 298-309.
  • Topper JN, Girnbrone MA Jr. (1999). Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype. Mol Med To-day 5: 40-46.
  • Tronc F, Mallat Z, Lehoux S, Wassef M, Esposito B, Tedgui A. (2000). Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interac-tion with NO. Arterioscler Thromb Vasc Biol 20: E120-E126.
  • Tsao PS, Wang B, Buitrago R, Shyy JY, Cooke JP. (1997). Nitric oxide regulates monocyte chemotactic protein-i. Circulation 96: 934-940.
  • Tuttle JL, Nachreiner RD, Bhuller AS, Condict KW, Connors BA, Herring BP, Dalsing MC, Unthank JL. (2001). Shear level influences resistance artery re-modeling: wall dimensions, cell density, and eNOS expression. Am J Physiol Heart Circ Physiol 281: H1380-H1389.
  • Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch MT, Scheinowitz M, Correa R, Klingbeil C, Epstein SE. (1994). Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 266: H1588-H1595.
  • Unthank JL, Fath SW, Burkhart HM, Miller SC, Dalsing MC. (1996). Wall remodeling during lumi-nal expansion of mesenteric arterial collaterals in the rat. Circ Res 79: 1015-1023.
  • Unthank JL, Nixon JC, Burkhart HM, Fath SW, Dalsing MC. (1996). Early collateral and microvas-cular adaptations to intestinal artery occlusion in rat. Am J Physiol 271: H914-H923.
  • Unthank JL, Nixon JC, Lash IM. (1995). Early ad-aptations in collateral and microvascular resistances after ligation of the rat femoral artery. J Appl Phys-iol 79: 73-82.
  • van Royen N, Hoefer I, Buschrnann I, Heil M, Kostin S, Deindl E, Vogel S, Korff T, Augustin H, Bode C, Piek JJ, Schaper W. (2002). Exogenous application of transforming growth factor beta 1 stimulates ar-teriogenesis in the peripheral circulation. FASER J 16: 432-434.
  • Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB. (1987). Transforming growth factor type beta in-duces monocyte chemotaxis and growth factor pro-duction. Proc Natl Acad Sci USA 84: 5788-5792.
  • Walpola PL, Gotlieb AT, Cybulsky MI, Langille BL. (1995). Expression of ICA1VI-1 and VCA1VI-1 and monocyte adherence in arteries exposed to altered shear stress. Arterioscler Thromb Vasc Biol 15: 2-10.
  • Warwick R, Williams PL. editors. Gray's Anatomy. 35th edition. Edinburgh, Scotland, UK: Longman, 1973.
  • Wei L, Erinjeri JP, Rovainen CM, Woolsey TA. (2001). Collateral growth and angiogenesis around cortical stroke. Stroke 32: 2179-2184.
  • White CR, Haidekker M, Bao X, Frangos JA. (2001). Temporal gradients in shear, but not spatial gradients, stimulate endothelial cell proliferation. Circulation 103: 2508-2513.
  • White FC, Bloor CM. (1992). Coronary vascular re-modeling and coronary resistance during chronic ischemia. Am J Cardiovasc Pathol 4: 193-202.
  • White FC, Bloor CM, McKirnan MD, Carroll SM. (1998). Exercise training in swine promotes growth of arteriolar bed and capillary angiogenesis in heart. J Appl Physiol 85: 1160-1168.
  • White FC, Carroll SM, Magnet A, Bloor CM. (1992). Coronary collateral development in swine after coro-nary artery occlusion. Circ Res 71: 1490-1500.
  • Wolf C, Cai WJ, Vosschulte R, Koltai S, Mousavi-pour D, Scholz D, Afsah-Hedjri A, Schaper W, Schaper J. (1998). Vascular remodeling and altered protein expression during growth of coronary collat-eral arteries. J Mol Cell Cardiol 30: 2291-2305.
  • Xu XY, Long Q, Collins MW, Bourne M, Griffith TM. (1999). Reconstruction of blood flow patterns in human arteries. Proc Inst Mech Eng [H] 213: 411-21.
  • Yamamoto H, Tomoike H, Shirnokawa H, Na-beyarna S, Nakamura M. (1984). Development of collateral function with repetitive coronary occlu-sion in a canine model reduces myocardial reactive hyperemia in the absence of significant coronary ste-nosis. Circ Res 55: 623-632.
  • Yanagisawa-Miwa A, Uchida Y, Nakamura F, To-maru T, Kido H, Karnijo T, Sugimoto T, Kaji K, Utsuyarna M, Kurashirna C, et al. (1992). Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257: 1401-1403.
  • Yang HT, Deschenes MR, Ogilvie RW, Terjung RL. (1996). Basic fibroblast growth factor increases col-lateral blood flow in rats with femoral arterial liga-tion. Circ Res 79: 62-69.
  • Yang HT, Ren J, Laughlin MH, Terjung RL. (2002). Prior exercise training produces NO-dependent in-creases in collateral blood flow after acute arterial occlusion. Am J Physiol Heart Circ Physiol 282: H301-H310.
  • Yang JH, Sakamoto H, Xu EC, Lee RT. (2000). Biomechanical regulation of human monocyte/ macrophage molecular function. Am J Pathol 156: 1797-1804.
  • Yu SM, Hung LM, Lin CC. (1997). cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epider-mal growth factor signaling pathway. Circulation 95: 1269-1277.
  • Zarins CK, Zatina MA, Giddens DP, Ku DN, Glagov S. (1987). Shear stress regulation of artery lumen diameter in experimental atherogenesis. J Vasc Surg 5: 413-420.
  • Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R. (1997). Nitric oxide synthase lies downstream from vascular endo-thelial growth factor-induced but not basic fibro-blast growth factor-induced angiogenesis. J Clin In-vest 99: 2625-2634.
  • Ziegelhoeffer T, Hoefer IE, van Royen N, Bus-chrnann IR. (1999). Effective reduction in collateral artery formation through matrix metalloproteinase inhibitors. Circulation 100 (suppl) : 1-705. Abstract 3719.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.